These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29742097)

  • 1. Advances in aggressive lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 5(2):1-24. PubMed ID: 29742097
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in aggressive lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition: commentary.
    Locke FL; Haroun F
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 5(2):19-23. PubMed ID: 29742098
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in lymphoma and leukemia from the 2016 American Society of Hematology annual meeting and exposition.
    Clin Adv Hematol Oncol; 2017 Mar; 15 Suppl 3(3):1-24. PubMed ID: 28590461
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in lymphoma and leukemia from the 2016 American Society of Hematology annual meeting and exposition: Commentary.
    Fowler NH
    Clin Adv Hematol Oncol; 2017 Mar; 15 Suppl 3(3):21-23. PubMed ID: 28590462
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in lymphoma from the 2014 American Society of Hematology annual meeting and exposition.
    Clin Adv Hematol Oncol; 2015 Feb; 13(2 Suppl 2):1-23. PubMed ID: 25775207
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in lymphoma from the 2016 American Society of Hematology annual meeting and exposition: Commentary.
    Horwitz SM
    Clin Adv Hematol Oncol; 2017 Feb; 15 Suppl 1(2):20-23. PubMed ID: 28590460
    [No Abstract]   [Full Text] [Related]  

  • 7. American Society of Hematology--51st annual meeting & exposition. Part 1.
    Shumoogam J; Beecher N
    IDrugs; 2010 Feb; 13(2):57-9. PubMed ID: 20127549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights in lymphoma from the 2012 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2013 Feb; 11(2 Suppl 3):6-23. PubMed ID: 23604200
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Bartlett NL
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 6(2):18-23. PubMed ID: 25856285
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 6(2):3-18. PubMed ID: 25856284
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 3(2):1-24. PubMed ID: 29742095
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 5(2):6-18. PubMed ID: 25856173
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Horwitz SM
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 5(2):19-22. PubMed ID: 25856174
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the treatment of lymphoma.
    Clin Adv Hematol Oncol; 2008 Feb; 6(2 Suppl 4):1-12; discussion 13-4; quiz 15-6. PubMed ID: 18347557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights in T-cell lymphoma from the 2011 American Society of Hematology Annual Meeting and Exposition.
    Horwitz SM
    Clin Adv Hematol Oncol; 2012 Mar; 10(3 Suppl 3):1-24. PubMed ID: 22398731
    [No Abstract]   [Full Text] [Related]  

  • 18. American society of hematology: 56th annual meeting and exposition.
    Alexander W
    P T; 2015 Feb; 40(2):133-5. PubMed ID: 25673964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the treatment of multiple myeloma. A Review of Selected Presentations From the 52nd American Society of Hematology Annual Meeting and Exposition.
    Jagannath S
    Clin Adv Hematol Oncol; 2011 Mar; 9(3 Suppl 4):1-16. PubMed ID: 21478821
    [No Abstract]   [Full Text] [Related]  

  • 20. Highlights in mantle cell lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Apr; 19 Suppl 13(4):1-20. PubMed ID: 35290295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.